Serotonin toxicity rarely announces itself with one defining symptom. Recognition depends on exposure context, clinical pattern, and neuromuscular findings.
Context before conclusion
Concern begins with a plausible serotonergic exposure or change. Choose the medication history that creates the clearest new serotonergic exposure.
Three domains, one pattern
Activate each domain. The picture becomes more useful as clinical findings are integrated rather than counted.
Neuromuscular excitation—particularly clonus and hyperreflexia—provides important diagnostic information.
Not all movement is equivalent
An oscillatory movement may occur in serotonin toxicity. Tremor paired with hyperreflexia constitutes one Hunter decision rule.
Apply a decision rule
Clinical vignette
A 28-year-old patient takes sertraline. Linezolid is started for an infection. Twelve hours later, the patient becomes agitated and diaphoretic. Examination reveals inducible ankle clonus and hyperreflexia.
Which Hunter decision-rule pathway is satisfied?
Severity is a continuum
Pattern
Final decision
The clinical takeaway
Dunkley, E. J. C., Isbister, G. K., Sibbritt, D., Dawson, A. H., & Whyte, I. M. (2003). The Hunter Serotonin Toxicity Criteria: Simple and accurate diagnostic decision rules for serotonin toxicity. QJM, 96(9), 635–642. https://doi.org/10.1093/qjmed/hcg109
Chiew, A. L., & Isbister, G. K. (2024). Management of serotonin syndrome (toxicity). British Journal of Clinical Pharmacology. Advance online publication. https://pmc.ncbi.nlm.nih.gov/articles/PMC11862804/
Scotton, W. J., Hill, L. J., Williams, A. C., & Barnes, N. M. (2019). Serotonin syndrome: Pathophysiology, clinical features, management, and potential future directions. International Journal of Tryptophan Research, 12. https://doi.org/10.1177/1178646919873925
